Bulgarian Patent Office v. AstraZeneca, Supreme Administrative Court (Bърховен касационен съд), 18 October 2011
The Supreme Administrative Court –overruled the Patent Office (PO) denying AstraZeneca’s application for a supplementary protection certificate (SPC), because the PO should have applied § 77(2) – instead of §79 – of the Transitional and Closing Provisions of the Act amending the Bulgarian Patents Act, which does not contains any requirements relating to the product’s…